<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18093" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Bacteremia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Smith</surname>
            <given-names>David A.</given-names>
          </name>
          <aff>Salus University/PVAMC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nehring</surname>
            <given-names>Sara M.</given-names>
          </name>
          <aff>St Bernards Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>David Smith declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sara Nehring declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18093.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Bacteremia, in the strictest sense, refers to viable bacteria in the blood. Asymptomatic bacteremia can occur in normal daily activities such as conducting oral hygiene and after minor medical procedures. In a healthy person, these clinically benign infections are transient and cause no further sequelae. However, when immune response mechanisms fail or become overwhelmed, bacteremia becomes a bloodstream infection that can evolve into many clinical spectrums and is differentiated as septicemia. This activity describes the causes and presentation of bacteremia and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of bacteremia.</p></list-item><list-item><p>Outline the workup of a patient with bacteremia.</p></list-item><list-item><p>Review the treatment and management options available for bacteremia.</p></list-item><list-item><p>Explain the interprofessional team strategies for improving care coordination and communication regarding the management of patients with bacteremia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18093&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18093">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18093.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Bacteremia, in the strictest sense, refers to viable bacteria in the blood. Asymptomatic bacteremia can occur in normal daily activities such as conducting oral hygiene and after minor medical procedures. In a healthy person, these clinically benign infections are transient and cause no further sequelae. However, when immune response mechanisms fail or become overwhelmed, bacteremia becomes a bloodstream infection that can evolve into many clinical spectrums and is differentiated as septicemia. Untreated and clinically significant bacteremia progresses to systemic inflammatory response syndrome (SIRS), sepsis, septic shock, and multiple organ dysfunction syndrome (MODS).&#x000a0;<xref ref-type="bibr" rid="article-18093.r1">[1]</xref><xref ref-type="bibr" rid="article-18093.r2">[2]</xref><xref ref-type="bibr" rid="article-18093.r3">[3]</xref></p>
      </sec>
      <sec id="article-18093.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Determining the primary source of infection is critical in the management of a patient with bacteremia, as well as in the identification of the affected patient population. Common sources in hospitalized patients include the respiratory tract and indwelling catheters, specifically central venous catheters. Untreated urinary tract infections most commonly cause community-acquired bacteremia. Soft tissue and intraabdominal infections are not as common and are more prevalent in the post-operative&#x000a0;surgical setting. <italic toggle="yes">Escherichia&#x000a0;coli</italic> is the most common cause of gram-negative associated bacteremia, while <italic toggle="yes">Staphylococcus aureus</italic> is the most common gram-positive organism.<xref ref-type="bibr" rid="article-18093.r4">[4]</xref><xref ref-type="bibr" rid="article-18093.r5">[5]</xref><xref ref-type="bibr" rid="article-18093.r6">[6]</xref></p>
      </sec>
      <sec id="article-18093.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>&#x000a0;Geographic region, patient population, drug resistance, and infection prevention practices at each institution drive the causative organisms of bloodstream infections. Taking into account that older patients with multiple comorbidities are more likely to reside in community centers and be hospitalized, it is no surprise that&#x000a0;they are at an increased risk of developing bacteremia. Traditionally gram-negative bacilli were the driving force for most hospital-acquired bloodstream infections in the United States and are still the most common organism associated with community-acquired bacteremia. However, with the onset of an aging population and device-related procedures, gram-positive aerobes have seen an increase in prevalence over the last two decades.&#x000a0;<xref ref-type="bibr" rid="article-18093.r3">[3]</xref><xref ref-type="bibr" rid="article-18093.r7">[7]</xref><xref ref-type="bibr" rid="article-18093.r8">[8]</xref></p>
      </sec>
      <sec id="article-18093.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>All bacterial infections are dependent on the host immune system, which is affected by their genetic signature, as well as congenital and acquired deficiencies. Cellular innate and adaptive immune responses are responsible for initial microbe clearance, while the liver and spleen filter active bacteria in the circulating blood. In its most basic form, bacteria will begin to&#x000a0;colonize at its primary source of location. At this point, the bacteria may become transient and clinically insignificant or can escape the host immune response and increase in number and become a local infection that can eventually migrate to other parts of the body. If the bacteria are viable and enter the circulating bloodstream, the infection still may spontaneously clear or progress to septicemia. The first barrier to bacterial invasion is the skin and mucosal surfaces. Conditions that interfere with these natural defense barriers commonly include medical procedures that pass through the skin and anatomical lumina. Additionally, events can precipitate defense breakdown via trauma, burns, ulcers, and the natural elements of aging.<xref ref-type="bibr" rid="article-18093.r6">[6]</xref></p>
      </sec>
      <sec id="article-18093.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The classical presentation in a bacteremic patient is&#x000a0;the presence of&#x000a0;a&#x000a0;fever. Chills and/or rigors do not need to present; however, the presence of&#x000a0;such signs should clue the provider that a febrile patient is now bacteremic. The development of septicemia leading to sepsis and septic shock will commonly cause hypotension, altered mental status, &#x000a0;and decreased urine output due to hypovolemia from leaking capillaries. As the infection disseminates, other organs can become affected, causing acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI).</p>
      </sec>
      <sec id="article-18093.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Identifying or presuming the source of infection will dictate the diagnostic measures taken. There should be a low threshold for ordering labs and imaging since time is of the essence in preventing septicemia. Initial labs in all presumed bacteremic patients should include a lactate level and blood cultures; ideally, two sets assessing for aerobic and anaerobic organisms from each arm. In the hospital setting, most patients, at a minimum, will require a chest x-ray and urinalysis with culture. A surgical patient may require CT imaging of the location of their surgery to assess for abscess or collection formation,&#x000a0;as well as&#x000a0;wound cultures for surgical site infections. Likewise, an intubated or patient presenting with pulmonary disease will require sputum cultures. Patients with indwelling venous catheters, hemodialysis catheters, or ports should have their lines removed and tips cultured.<xref ref-type="bibr" rid="article-18093.r9">[9]</xref><xref ref-type="bibr" rid="article-18093.r10">[10]</xref></p>
      </sec>
      <sec id="article-18093.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Bacteremia requires urgent and appropriate&#x000a0;antibiotics. Delay in the administration of appropriate antibiotics is associated with increased morbidity and mortality. Empiric antibiotics should follow a logical approach based on the patient's history and current disposition. For example, is the infection community or&#x000a0;hospital-acquired, what is the patient's recent healthcare exposure, recent medical or surgical treatment, and what is the local antibiotic resistance? Before a Gram stain is finalized, all patients should receive broad-spectrum antibiotics covering gram-positive and gram-negative bacteria, which include extended-generation cephalosporins or a beta-lactamase inhibitor. Pseudomonas coverage is applicable for hospital-acquired bacteremia, as well as in a patient with recent health care exposure. Additionally, vancomycin should be added to cover resistant gram-positive organisms, most notably methicillin-resistant&#x000a0;resistant Staphylococcus aureus (MRSA). When the practitioner&#x000a0;obtains the final cultures, antibiotics should be titrated to directed therapy starting with the gram stain, and eventually, antimicrobial susceptibility. There is no optimal duration of treatment. In most cases, antibiotic treatment should continue for seven to 14 days and should always be administered parenterally. Oral agents are recommended when patients have been afebrile for at least 48 hours and are otherwise clinically stable.<xref ref-type="bibr" rid="article-18093.r11">[11]</xref><xref ref-type="bibr" rid="article-18093.r12">[12]</xref><xref ref-type="bibr" rid="article-18093.r13">[13]</xref></p>
      </sec>
      <sec id="article-18093.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute prostatitis / abscess</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Community-acquired pneumonia (with asplenia)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Deep neck space infection abscess</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Empyema</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Instrumentation in patients with bacteriuria</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Intra- or perinephric abscess</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lung abscess</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Peritonitis abscess</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pyelonephritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Renal calculi</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Renal insufficiency</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Urinary tract obstruction</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18093.s10" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Endocarditis</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18093.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>Infectious disease consultation is usually indicated.</p>
      </sec>
      <sec id="article-18093.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>As with most infectious diseases, preventive practice&#x000a0;is critical in the outpatient and inpatient setting. All healthcare workers play an important role in the prevention of bacterial infections in the workplace. At the most rudimentary level, basic hand hygiene and the adherence to clean and sterile techniques are&#x000a0;critical in preventing and decreasing the prevalence of bloodstream infections. Preventative&#x000a0;practice starts not only at the beginning of a procedure but also throughout daily maintenance of line care. Even with strict adherence to infection control, many patients will&#x000a0;succumb to a bloodstream infection. Recognizing the predominant organisms associated with each clinical setting&#x000a0;can prevent mortality&#x000a0;as bloodstream pathogens such as <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Pseudomonas&#x000a0;aeruginosa</italic>, and <italic toggle="yes">Enterobacter</italic>&#x000a0;species are associated with a higher mortality rate. Prevention also includes the judicious use of antibiotics, which must take into effect the risk and reward of antibiotic use.&#x000a0;The&#x000a0;rising prevalence of multi-drug-resistant bacteria has complicated treatment over the years and will continue to do so. This&#x000a0;rise makes education, prevention, and adherence to protocol a necessity to counter the debilitating effects of bloodstream infections. Patient isolation, preventing airborne, and contact infections are also key factors that must be controlled. Today, all healthcare facilities have an infectious disease committee that oversees the use of antibiotics, prescribing habits of healthcare providers, and ensures that invasive and other bedside procedures are done under sterile conditions. The key to lowering the morbidity of bacteremia is the education of the healthcare provider. an interprofessional team consisting of physicians, nurse practitioners, specialty care nurses, and pharmacists will improve outcomes. Pharmacists evaluate drug selection, doses, and interactions. Critical care and medical-surgical nurses administer treatments, monitor patients, and are crucial in the notification of the team as to changes in status. Infection control nurses often follow up to ensure the quality of care. <xref ref-type="bibr" rid="article-18093.r3">[3]</xref><xref ref-type="bibr" rid="article-18093.r14">[14]</xref><xref ref-type="bibr" rid="article-18093.r15">[15]</xref>[Level V]</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Patients with bacteremia who are treated with antibiotics or observed have good outcomes. But rarely the bacteremia may cause endocarditis, osteomyelitis, pneumonia, cellulitis, meningitis sepsis and multiorgan dysfunction, followed by death. Over the past four decades, the availability of better antibiotics and vaccination has resulted in lower mortality rates in people of all ages. Prior to the era of vaccination, the mortality rates from bacteremia were over 20%. Today, the biggest concern in the development of antibiotic resistance which is now common against most organisms. Many guidelines have been developed to manage children and seniors with fever and bacteremia, but the bottom line is that one should always be aware of the potential of harm if the observation is selected as a method of treatment.<xref ref-type="bibr" rid="article-18093.r16">[16]</xref><xref ref-type="bibr" rid="article-18093.r17">[17]</xref><xref ref-type="bibr" rid="article-18093.r18">[18]</xref> [Level 5]</p>
      </sec>
      <sec id="article-18093.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18093&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18093">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/bacteremia-bloodstream-bacteria/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18093">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18093/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18093">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18093.s14">
        <title>References</title>
        <ref id="article-18093.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler-Laporte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De L'&#x000c9;toile-Morel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis.</article-title>
            <source>J Infect</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>489</fpage>
            <page-range>489-495</page-range>
            <pub-id pub-id-type="pmid">30102944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dagasso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Conley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parfitt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pasquill</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Laupland</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Risk factors associated with bloodstream infections in end-stage renal disease patients: a population-based study.</article-title>
            <source>Infect Dis (Lond)</source>
            <year>2018</year>
            <season>Nov-Dec</season>
            <volume>50</volume>
            <issue>11-12</issue>
            <fpage>831</fpage>
            <page-range>831-836</page-range>
            <pub-id pub-id-type="pmid">30156131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arcens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stirnemann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mayor</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Epidemiology and strategy to prevent urinary catheters related complications].</article-title>
            <source>Rev Med Suisse</source>
            <year>2018</year>
            <month>Aug</month>
            <day>29</day>
            <volume>14</volume>
            <issue>616</issue>
            <fpage>1518</fpage>
            <page-range>1518-1521</page-range>
            <pub-id pub-id-type="pmid">30156786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munro</surname>
                <given-names>APS</given-names>
              </name>
              <name>
                <surname>Blyth</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children's hospital.</article-title>
            <source>BMC Infect Dis</source>
            <year>2018</year>
            <month>Aug</month>
            <day>10</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>387</fpage>
            <pub-id pub-id-type="pmid">30097020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antonio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gudiol</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Royo-Cebrecos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grillo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ardanuy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carratal&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors.</article-title>
            <source>J Geriatr Oncol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>246</fpage>
            <page-range>246-251</page-range>
            <pub-id pub-id-type="pmid">30005979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woll</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Neuman</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Pruitt</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>McCulloh</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Nigrovic</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>DePorre</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Leazer</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Marble</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Balamuth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Sartori</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Browning</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Aronson</surname>
                <given-names>PL</given-names>
              </name>
              <collab>Febrile Young Infant Research Collaborative</collab>
            </person-group>
            <article-title>Epidemiology and Etiology of Invasive Bacterial Infection in Infants &#x02264;60 Days Old Treated in Emergency Departments.</article-title>
            <source>J Pediatr</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>200</volume>
            <fpage>210</fpage>
            <page-range>210-217.e1</page-range>
            <pub-id pub-id-type="pmid">29784512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lishman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Costelloe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Hope</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muller-Pebody</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aylin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>790</fpage>
            <page-range>790-798</page-range>
            <pub-id pub-id-type="pmid">30145249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dierig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agyeman</surname>
                <given-names>PKA</given-names>
              </name>
              <name>
                <surname>Bernhard-Stirnemann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giannoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stocker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Posfay-Barbe</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Niederer-Loher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kahlert</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Donas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hasters</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Relly</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Riedel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aebi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schlapbach</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Heininger</surname>
                <given-names>U</given-names>
              </name>
              <collab>Swiss Pediatric Sepsis Study</collab>
            </person-group>
            <article-title>Time-to-Positivity of Blood Cultures in Children With Sepsis.</article-title>
            <source>Front Pediatr</source>
            <year>2018</year>
            <volume>6</volume>
            <fpage>222</fpage>
            <pub-id pub-id-type="pmid">30135859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Libertin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Sacco</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Education and coaching to optimise blood culture volumes: continuous quality improvement in microbiology.</article-title>
            <source>BMJ Open Qual</source>
            <year>2018</year>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>e000228</fpage>
            <pub-id pub-id-type="pmid">30057953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Lasky-Su</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Caterino</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hagan</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lyman</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Baden</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Glotzbecker</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Coyne</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Baugh</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Pallin</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Integrative omics to detect bacteremia in patients with febrile neutropenia.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>e0197049</fpage>
            <pub-id pub-id-type="pmid">29768470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arientov&#x000e1;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beran</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>&#x00160;tefan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x0010c;urdov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holub</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bacteremia due to Staphylococcus aureus - the importance of appropriate management.</article-title>
            <source>Epidemiol Mikrobiol Imunol</source>
            <year>2018</year>
            <season>Spring</season>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>88</fpage>
            <page-range>88-91</page-range>
            <pub-id pub-id-type="pmid">30126286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhat</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Snehaa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Bloodstream infections and trends of antimicrobial sensitivity patterns at Port Blair.</article-title>
            <source>J Lab Physicians</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>332</fpage>
            <page-range>332-337</page-range>
            <pub-id pub-id-type="pmid">30078972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rapoport</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Santibanez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beekmann</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Polgreen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Rowley</surname>
                <given-names>CF</given-names>
              </name>
            </person-group>
            <article-title>Infectious Diseases Physicians' Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>7</issue>
            <fpage>ofy132</fpage>
            <pub-id pub-id-type="pmid">30018999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beeler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dbeibo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kelley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thatcher</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monahan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Nicol</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Judy-Malcolm</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Azar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Assessing patient risk of central line-associated bacteremia via machine learning.</article-title>
            <source>Am J Infect Control</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>46</volume>
            <issue>9</issue>
            <fpage>986</fpage>
            <page-range>986-991</page-range>
            <pub-id pub-id-type="pmid">29661634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morrison</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>eNews Tool to Prevent Central Line-Associated Bloodstream Infection.</article-title>
            <source>Comput Inform Nurs</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>161</fpage>
            <page-range>161-165</page-range>
            <pub-id pub-id-type="pmid">29620619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mogle</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Seabury</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>UJ</given-names>
              </name>
              <name>
                <surname>Kufel</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>805</fpage>
            <page-range>805-810</page-range>
            <pub-id pub-id-type="pmid">30176357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Teng</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>High mortality impact of Staphylococcus argenteus on patients with community-onset staphylococcal bacteraemia.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>747</fpage>
            <page-range>747-753</page-range>
            <pub-id pub-id-type="pmid">30149137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18093.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bidell</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>73</volume>
            <issue>10</issue>
            <fpage>2643</fpage>
            <page-range>2643-2651</page-range>
            <pub-id pub-id-type="pmid">30085140</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
